Based on these findings, the heterogenicity of cSCC tumors may indicate that in some cSCC cells in which ERK1/2 activity is low, the expression of BRD3OS (LINC00094) might increase and thus promote the invasion of these cells. The gene discussed is MAPK3; the disease is skin squamous cell carcinoma.